Radioimmunotherapy is a combination of radiation therapy and immunotherapy.
Pediatric leukemia patient Emma Duffin is in remission, thanks to the stem cell transplant made possible by her brother, Alexander.
Leukemia is a type of cancer that starts in early forms of white blood cells. White blood cells are cells that typically fight infections.
People diagnosed with precursor conditions that often lead to multiple myeloma currently have little way of gauging their risk of myeloma or knowing when, if ever, the disease might progress.
Are massages harmful for someone undergoing cancer treatment? Is it really possible they could spread lymphoma? The simple answer: No.
The word “refractory” in general use means stubborn or intractable, and in medicine it is specifically applied to disease that does not respond to treatment. Refractory cancer refers to cancer that may be resistant at the beginning of treatment, or becomes resistant during treatment. “We would consider disease refractory if […]
Survival rates associated with blood cancers such as leukemia, lymphoma, and multiple myeloma have risen for patients of all ages in recent years, but this increase has been relatively smaller in adolescents and young adults – those aged 15-40 – than in children and older adults. There are likely to […]
In a bone marrow biopsy, a doctor uses a needle to remove and examine a small amount of bone marrow, the spongy tissue inside some of the body’s larger bones. Bone marrow, which generates all the different kinds of cells within the blood, has the consistency of a gel in […]
The vow Chukwuma Anyanwu made to himself shortly after the birth of his third child in June 2015 speaks volumes, not only about the dire state of his health at the time but also about the mettle with which he is made. “My goal was to be able to walk […]
Dany Hilaire, PhD, RN, will never forget the day she decided to become a nurse. It was one of the saddest of her life. Her father had just died, and his nurses now turned their attention to Hilaire, her mother, and her siblings. “I remember one of them giving me […]
Treatment of blood-related, or hematologic, cancers is seizing on insights into the basic genetic wiring of cancer cells and the body’s system for finding and attacking those cells. Research presentations at the annual American Society of Hematology (ASH) meeting in December gave evidence of how broad, and rapid, the progress […]
Because of their increased susceptibility to the toxicities of chemotherapy, should ALL patients with Down syndrome receive modified treatment to minimize this risk? Or should they be given the same treatment as other children with ALL, to minimize the chance for relapse?
The ball leaps off the metal bat with an unmistakable “ping” that denotes good contact. Miles Goldberg runs to first base, from which the 13-year-old will soon contemplate – and safely execute – a steal of second. Miles is used to transitioning naturally with the seasons from football to hockey […]
It might sound counterintuitive, but not every patient comes to Dana-Farber for cancer treatment. For example, the Institute’s experts regularly see patients seeking help with benign (non-cancerous) blood disorders. Benign blood disorders such as anemia and sickle cell disease are often treated at cancer centers because such institutions are home […]
Jessica Madsen wasn’t sure if her daughter, Addy, was ready for karate, until the 4-year-old got the chance to take free lessons in the most surprising place: Her hospital room. Addy and other stem cell transplant recipients at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center are offered free martial arts […]
The last two years have been very exciting for blood cancer research; many new targeted therapies and immunotherapies are improving treatment outcomes for patients with lymphoma, leukemia and multiple myeloma. “We’re starting to see a lot of hematologic malignancies benefit from immunotherapy,” says Irene Ghobrial, MD. “The excitement is there […]
At its most basic level, gene therapy is a powerful technique for correcting mistakes (called mutations) in DNA of human cells. Lately, the therapy has been gaining traction as a potentially life-saving treatment for children with an array of inherited rare blood and immune disorders, as well as certain cancers. […]
Joe Yannetty earns a living making people laugh, so when it came to thanking his caregivers at Dana-Farber/New Hampshire Oncology-Hematology (DF/NHOH) for the successful treatment of his throat cancer, candy or flowers just wasn’t going to cut it. For Yannetty, a Boston-based comedian since 1983, gratitude was best expressed by doing what […]
Avery McAvoy’s last day in the hospital was a long-awaited milestone, but all the 2-year-old cared about was how it ended: with bubbles. After 12 months of treatment for neuroblastoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, much of which was spent on the inpatient oncology and hematology unit […]
In two recent books and the Ken Burns TV documentary, “Cancer: The Emperor of All Maladies”, prominent researchers explain eloquently why cancer is such a stubborn problem and detail how the latest treatment strategies are gaining ground – if slowly. “There have been so many wonderful changes,” says David G. […]